About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 762183, 7 pages
http://dx.doi.org/10.1155/2013/762183
Review Article

A MicroRNA Component of the Neoplastic Microenvironment: Microregulators with Far-Reaching Impact

Department of Molecular Biology, Institute of Basic Medicine, School of Life Sciences, Chinese PLA General Hospital, Beijing 100853, China

Received 31 May 2012; Revised 27 July 2012; Accepted 11 August 2012

Academic Editor: Juan Carlos Calvo

Copyright © 2013 Xiaolei Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Scopus
  3. M. Egeblad, E. S. Nakasone, and Z. Werb, “Tumors as organs: complex tissues that interface with the entire organism,” Developmental Cell, vol. 18, no. 6, pp. 884–901, 2010. View at Scopus
  4. P. Friedl and S. Alexander, “Cancer invasion and the microenvironment: plasticity and reciprocity,” Cell, vol. 147, no. 5, pp. 992–1009, 2011. View at Publisher · View at Google Scholar
  5. A. Orimo, P. B. Gupta, D. C. Sgroi et al., “Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion,” Cell, vol. 121, no. 3, pp. 335–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Polyak, “Breast cancer: origins and evolution,” Journal of Clinical Investigation, vol. 117, no. 11, pp. 3155–3163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Croce, “Causes and consequences of microRNA dysregulation in cancer,” Nature Reviews Genetics, vol. 10, no. 10, pp. 704–714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Dornan and J. Settleman, “Cancer: miRNA addiction—depending on life's little things,” Current Biology, vol. 20, no. 18, pp. R812–R813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Harris, “Hypoxia—a key regulatory factor in tumour growth,” Nature Reviews Cancer, vol. 2, no. 1, pp. 38–47, 2002. View at Scopus
  10. R. Kulshreshtha, M. Ferracin, S. E. Wojcik, et al., “A microRNA signature of hypoxia,” Molecular and Cellular Biology, vol. 27, no. 5, pp. 1859–1867, 2007.
  11. R. Kulshreshtha, R. V. Davuluri, G. A. Calin, and M. Ivan, “A microRNA component of the hypoxic response,” Cell Death and Differentiation, vol. 15, no. 4, pp. 667–671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. K. Wentz-Hunter and J. A. Potashkin, “The role of miRNAs as key regulators in the neoplastic microenvironment,” Molecular Biology International, vol. 2011, Article ID 839872, 8 pages, 2011. View at Publisher · View at Google Scholar
  13. Z. Hua, Q. Lv, W. Ye et al., “Mirna-directed regulation of VEGF and other angiogenic under hypoxia,” PLoS ONE, vol. 1, no. 1, article e116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Hebert, K. Norris, M. A. Scheper, N. Nikitakis, and J. J. Sauk, “High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma,” Molecular Cancer, vol. 6, article 5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. B. Donker, J. F. Mouillet, D. M. Nelson, and Y. Sadovsky, “The expression of Argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts,” Molecular Human Reproduction, vol. 13, no. 4, pp. 273–279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. W. W. Hwang-Verslues, P. H. Chang, P. C. Wei et al., “MiR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1,” Oncogene, vol. 30, no. 21, pp. 2463–2474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Gabriely, T. Wurdinger, S. Kesari et al., “MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators,” Molecular and Cellular Biology, vol. 28, no. 17, pp. 5369–5380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Chan, A. M. Krichevsky, and K. S. Kosik, “MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells,” Cancer Research, vol. 65, no. 14, pp. 6029–6033, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. I. A. Babar, J. Czochor, A. Steinmetz, et al., “Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells,” Cancer Biology and Therapy, vol. 12, no. 10, pp. 908–914, 2011.
  20. M. E. Crosby, C. M. Devlin, P. M. Glazer, G. A. Calin, and M. Ivan, “Emerging roles of microRNAs in the molecular responses to hypoxia,” Current Pharmaceutical Design, vol. 15, no. 33, pp. 3861–3866, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Crosby, R. Kulshreshtha, M. Ivan, and P. M. Glazer, “MicroRNA regulation of DNA repair gene expression in hypoxic stress,” Cancer Research, vol. 69, no. 3, pp. 1221–1229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Volinia, G. A. Calin, C. G. Liu, et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar
  23. C. Camps, F. M. Buffa, S. Colella et al., “Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer,” Clinical Cancer Research, vol. 14, no. 5, pp. 1340–1348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. P. Porkka, M. J. Pfeiffer, K. K. Waltering, R. L. Vessella, T. L. J. Tammela, and T. Visakorpi, “MicroRNA expression profiling in prostate cancer,” Cancer Research, vol. 67, no. 13, pp. 6130–6135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Foekens, A. M. Sieuwerts, M. Smid et al., “Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13021–13026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. H. Lawrie, S. Gal, H. M. Dunlop et al., “Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma,” British Journal of Haematology, vol. 141, no. 5, pp. 672–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Huang, K. Gumireddy, M. Schrier et al., “The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis,” Nature Cell Biology, vol. 10, no. 2, pp. 202–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. M. Voorhoeve, C. le Sage, M. Schrier et al., “A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors,” Cell, vol. 124, no. 6, pp. 1169–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. F. Place, L. C. Li, D. Pookot, E. J. Noonan, and R. Dahiya, “MicroRNA-373 induces expression of genes with complementary promoter sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1608–1613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. G. A. Calin, C. D. Dumitru, M. Shimizu et al., “Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15524–15529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Migliazza, F. Bosch, H. Komatsu et al., “Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia,” Blood, vol. 97, no. 7, pp. 2098–2104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, “Identification of novel genes coding for small expressed RNAs,” Science, vol. 294, no. 5543, pp. 853–858, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. U. Klein, M. Lia, M. Crespo et al., “The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia,” Cancer Cell, vol. 17, no. 1, pp. 28–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Yamakuchi, S. Yagi, T. Ito, and C. J. Lowenstein, “Microrna-22 regulates hypoxia signaling in colon cancer cells,” PLoS ONE, vol. 6, no. 5, Article ID e20291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Xiong, J. H. Fang, J. P. Yun et al., “Effects of microrna-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma,” Hepatology, vol. 51, no. 3, pp. 836–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Yamakuchi, C. D. Lotterman, C. Bao et al., “P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6334–6339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Xu, L. Z. Liu, X. Qian, et al., “MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis,” Nucleic Acids Research, vol. 40, no. 2, pp. 761–774, 2012. View at Publisher · View at Google Scholar
  38. S. T. Cha, P. S. Chen, G. Johansson et al., “MicroRNA-519c suppresses hypoxia-inducible factor-1α expression and tumor angiogenesis,” Cancer Research, vol. 70, no. 7, pp. 2675–2685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Kulshreshtha, M. Ferracin, M. Negrini, G. A. Calin, R. V. Davuluri, and M. Ivan, “Regulation of microRNA expression: the hypoxic component,” Cell Cycle, vol. 6, no. 12, pp. 1426–1431, 2007. View at Scopus
  40. O. de Wever and M. Mareel, “Role of tissue stroma in cancer cell invasion,” Journal of Pathology, vol. 200, no. 4, pp. 429–447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Aboussekhra, “Role of cancer-associated fibroblasts in breast cancer development and prognosis,” International Journal of Developmental Biology, vol. 55, no. 7–9, pp. 841–849, 2011. View at Publisher · View at Google Scholar
  42. K. Kurose, K. Gilley, S. Matsumoto, P. H. Watson, X. P. Zhou, and C. Eng, “Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas,” Nature Genetics, vol. 32, no. 4, pp. 355–357, 2002. View at Publisher · View at Google Scholar
  43. R. Hill, Y. Song, R. D. Cardiff, and T. Van Dyke, “Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis,” Cell, vol. 123, no. 6, pp. 1001–1011, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Qiu, M. Hu, A. Sridhar et al., “No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas,” Nature Genetics, vol. 40, no. 5, pp. 650–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Yamamichi, R. Shimomura, K. I. Inada et al., “Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development,” Clinical Cancer Research, vol. 15, no. 12, pp. 4009–4016, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Rask, E. Balslev, S. Jørgensen et al., “High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer,” APMIS, vol. 119, no. 10, pp. 663–673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Lee, H. Y. Lee, E. S. Lee, et al., “Prognostic implications of microRNA-21 overexpression in invasive ductal carcinomas of the breast,” Journal of Breast Cancer, vol. 14, no. 4, pp. 269–275, 2011. View at Publisher · View at Google Scholar
  48. E. Giovannetti, N. Funel, G. J. Peters et al., “MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity,” Cancer Research, vol. 70, no. 11, pp. 4528–4538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. O. Aprelikova, X. Yu, J. Palla et al., “The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts,” Cell Cycle, vol. 9, no. 21, pp. 4387–4398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Musumeci, V. Coppola, A. Addario et al., “Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer,” Oncogene, vol. 30, no. 41, pp. 4231–4242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. K. J. Png, N. Halberg, M. Yoshida, and S. F. Tavazoie, “A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells,” Nature, vol. 481, no. 7380, pp. 190–194, 2012. View at Publisher · View at Google Scholar
  52. R. Rouas, H. Fayyad-Kazan, N. El Zien et al., “Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression,” European Journal of Immunology, vol. 39, no. 6, pp. 1608–1618, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Liu, Z. Zhan, L. Xu et al., “MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα,” Journal of Immunology, vol. 185, no. 12, pp. 7244–7251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Lu, V. M. Weaver, and Z. Werb, “The extracellular matrix: a dynamic niche in cancer progression,” The Journal of Cell Biology, vol. 196, no. 4, pp. 395–406, 2012. View at Publisher · View at Google Scholar
  55. M. Osaki, F. Takeshita, Y. Sugimoto et al., “MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression,” Molecular Therapy, vol. 19, no. 6, pp. 1123–1130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. B. Han, J. Gu, H. J. Zuo, et al., “Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer,” Journal of Pathology, vol. 226, no. 3, pp. 544–555, 2012. View at Publisher · View at Google Scholar
  57. H. Xia, Y. Qi, S. S. Ng et al., “microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs,” Brain Research, vol. 1269, pp. 158–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Liu and M. J. Wilson, “miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 867–876, 2012. View at Publisher · View at Google Scholar
  59. L. X. Yan, X. F. Huang, Q. Shao et al., “MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis,” RNA, vol. 14, no. 11, pp. 2348–2360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. F. M. Selaru, A. V. Olaru, T. Kan et al., “MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3,” Hepatology, vol. 49, no. 5, pp. 1595–1601, 2009. View at Publisher · View at Google Scholar · View at Scopus